Low Iron Symptoms: Labs to Order and What to Do Next

Why Iron Deficiency Is So Often Missed

Iron deficiency can exist for months or years before anemia appears on a standard complete blood count. The World Health Organization estimates that iron deficiency without anemia affects twice as many people as iron deficiency anemia itself [1]. A normal hemoglobin does not rule out the problem. Your body depletes storage iron (reflected by ferritin) long before red blood cell production falls.

Dr. Clara Camaschella, writing in the New England Journal of Medicine, described iron deficiency as "a condition that is underdiagnosed and undertreated, particularly in women of reproductive age" [2]. This gap matters because symptoms like fatigue, poor concentration, and exercise intolerance often get attributed to stress, poor sleep, or depression. The clinical overlap is real, but the fix for iron deficiency is straightforward once identified.

A 2023 Lancet Haematology systematic review of 55 studies (N=15,641) found that non-anemic iron deficiency significantly impaired quality of life scores, with fatigue being the dominant complaint across age groups and sexes [3]. Patients who received iron supplementation reported improved energy even when their hemoglobin had been "normal" all along.

The takeaway: symptoms alone should prompt lab testing. Waiting for anemia to develop means waiting too long.

Recognizing the Symptoms

The classic presentation of iron deficiency includes fatigue, pallor, dizziness, and shortness of breath on exertion. Those are the textbook signs. But several less obvious symptoms deserve attention because they point to the same underlying problem.

Fatigue and cognitive fog. A 2020 BMJ Open study of 1,692 women with ferritin levels <50 ng/mL found that 78% reported persistent fatigue and 63% described difficulty concentrating, compared to 31% and 22% of iron-replete controls [4].

Hair thinning and brittle nails. Iron is required for cell division in hair follicle matrix cells. The Journal of the American Academy of Dermatology published a meta-analysis (12 studies, N=3,209) showing that women with chronic telogen effluvium had significantly lower mean ferritin (22.4 ng/mL) than controls (56.2 ng/mL; P<0.001) [5].

Restless legs syndrome. The American Academy of Sleep Medicine guidelines recommend checking serum ferritin in all patients with restless legs syndrome, noting that ferritin <75 ng/mL warrants iron supplementation even in the absence of anemia [6].

Pica and pagophagia. Compulsive ice chewing is surprisingly specific for iron deficiency. It often resolves completely within days of starting oral iron.

Cold intolerance and poor exercise tolerance. Iron plays a direct role in oxygen transport and mitochondrial enzyme function. Even mild depletion reduces aerobic capacity.

Not every fatigued patient has iron deficiency. But every fatigued patient should have a ferritin level checked.

Which Labs to Order and How to Read Them

A complete iron evaluation requires four to five tests. Ordering serum iron alone is insufficient because it fluctuates throughout the day by as much as 30% and rises after a single iron-rich meal.

Serum ferritin is the single most useful test for iron stores. The WHO defines iron deficiency as ferritin <15 ng/mL [1], but the American Gastroenterological Association (AGA) and multiple hematology guidelines now use a cutoff of <30 ng/mL for clinical decision-making [7]. For patients with concurrent inflammation (CRP elevated), ferritin <100 ng/mL should raise suspicion because ferritin is an acute-phase reactant that rises independently during infection or chronic disease.

Complete blood count (CBC). Look for low hemoglobin (anemia threshold: <12 g/dL in women, <13 g/dL in men per WHO), low mean corpuscular volume (MCV <80 fL indicates microcytosis), and elevated red cell distribution width (RDW). Iron deficiency anemia is classically microcytic and hypochromic, but early-stage deficiency may show a normal MCV.

Serum iron and total iron-binding capacity (TIBC). Serum iron drops and TIBC rises when stores are depleted. The ratio of serum iron to TIBC gives the transferrin saturation. A transferrin saturation <20% supports iron deficiency [7].

Reticulocyte hemoglobin content (CHr or Ret-He). This newer marker reflects iron available for red blood cell production in real time. Values <28 pg suggest functional iron deficiency even when ferritin is borderline [8]. Not all labs offer it, but requesting it can clarify ambiguous cases.

C-reactive protein (CRP). Adding CRP to the panel helps interpret ferritin in the setting of infection, autoimmune disease, obesity, or malignancy.

Dr. Michael Auerbach, a professor at Georgetown University School of Medicine, has stated: "Ferritin is the gatekeeper, but it must be interpreted in clinical context. A ferritin of 40 in a patient with active Crohn's disease may represent true iron depletion masked by inflammation" [9].

Order the full panel. Partial testing leads to partial answers.

Common Causes and Who Is Most at Risk

Iron deficiency has three main mechanisms: inadequate intake, impaired absorption, and blood loss. Often two or three overlap in the same patient.

Menstrual blood loss is the leading cause in premenopausal women. A prospective study in the American Journal of Clinical Nutrition (N=949 women aged 18 to 45) found that 42% of women with heavy menstrual bleeding had ferritin <15 ng/mL, compared to 7% of women with normal flow [10]. Heavy periods are defined as more than 80 mL per cycle, but that volume is hard to measure in practice. Any patient who reports clots larger than a quarter, cycles lasting more than 7 days, or the need to double up on pads and tampons warrants screening.

GI blood loss is the most important cause in men and postmenopausal women. The British Society of Gastroenterology recommends bidirectional endoscopy (upper endoscopy and colonoscopy) for any male or postmenopausal female with unexplained iron deficiency anemia, because occult GI malignancy is found in up to 11% of these patients [11]. Celiac disease is another GI cause that is commonly missed. The AGA recommends celiac serologies (tissue transglutaminase IgA) in all patients with unexplained iron deficiency [7].

Impaired absorption. Conditions that reduce gastric acid (chronic PPI use, autoimmune gastritis, H. pylori infection, prior gastric bypass) decrease iron absorption. A 2017 meta-analysis in Alimentary Pharmacology and Therapeutics found that long-term PPI use was associated with a 2.6-fold increased risk of iron deficiency [12].

Inadequate dietary intake. Vegetarian and vegan diets contain only non-heme iron, which has a bioavailability of 2 to 20% compared to 15 to 35% for heme iron from animal sources. Athletes with high training volumes lose iron through sweat, GI microbleeding, and hemolysis, which is sometimes called "sports anemia."

Pregnancy and postpartum. Iron requirements increase to 27 mg/day during pregnancy (up from 18 mg/day in nonpregnant women). The American College of Obstetricians and Gynecologists (ACOG) recommends universal iron supplementation in pregnancy and screening for anemia at the first prenatal visit and again in the third trimester [13].

Oral Iron Therapy: First-Line Treatment

Oral iron remains the standard starting point for most patients with iron deficiency, with or without anemia. The goal is to replenish hemoglobin and refill ferritin stores to above 50 to 100 ng/mL.

Which formulation. Ferrous sulfate 325 mg (65 mg elemental iron) is the most widely studied and least expensive option. Ferrous gluconate (38 mg elemental iron per 325 mg tablet) and ferrous fumarate (106 mg elemental iron per 325 mg tablet) are alternatives with similar efficacy. The WHO recommends 100 to 200 mg of elemental iron daily for treatment of iron deficiency anemia in adults [1].

Every-other-day dosing. A landmark 2017 crossover study published in The Lancet Haematology (N=54) demonstrated that hepcidin, the master regulator of iron absorption, rises sharply 24 hours after a dose of oral iron and suppresses absorption of the next dose [14]. Fractional iron absorption from the second dose on consecutive days was 36% lower than from an alternate-day dose. This finding led to the now-widespread recommendation of every-other-day dosing, which improves absorption and reduces GI side effects.

Timing matters. Take oral iron on an empty stomach, at least one hour before meals, with a source of vitamin C (ascorbic acid 200 mg increases absorption by up to 67%) [15]. Avoid taking iron within two hours of antacids, calcium supplements, PPIs, coffee, or tea.

GI tolerability. Constipation, nausea, and dark stools are common. Every-other-day dosing helps. If standard ferrous sulfate is intolerable, switching to ferric maltol (Accrufer), an FDA-approved oral iron formulation, is an option. In the AEGIS-H2H trial, ferric maltol demonstrated comparable hemoglobin increases to IV iron sucrose at 12 weeks in patients with inflammatory bowel disease [16].

Expected response. Hemoglobin should rise 1 to 2 g/dL within 2 to 4 weeks. A reticulocyte count increase may be visible as early as 5 to 7 days. If there is no response after 4 to 6 weeks, consider adherence issues, ongoing blood loss, malabsorption, or an incorrect diagnosis. Continue oral iron for 3 to 6 months after hemoglobin normalizes to refill stores.

When IV Iron Is the Right Choice

Intravenous iron bypasses the gut entirely and delivers a full repletion dose in one to two sessions. It is not reserved for extreme cases. Several clinical scenarios make IV iron the preferred route.

Indications per AGA and AACE guidelines [7]:

• Oral iron intolerance or documented non-response after 4 to 6 weeks
• Hemoglobin <7 g/dL with symptoms requiring rapid correction
• Inflammatory bowel disease (absorption is often compromised)
• Chronic kidney disease, especially patients on hemodialysis
• Second or third trimester of pregnancy with hemoglobin <10 g/dL and insufficient response to oral therapy
• Active GI bleeding when oral iron cannot keep up with losses

Formulations. Ferric carboxymaltose (Injectafer) and iron sucrose (Venofer) are the most commonly used in the United States. Ferric carboxymaltose allows administration of 750 mg per infusion (two infusions one week apart for a total of 1,500 mg), while low-molecular-weight iron dextran (INFeD) can deliver 1,000 mg or more in a single session. Ferric derisomaltose (Monoferric) was FDA-approved in 2020 and permits a single infusion of up to 1,000 mg in 20 minutes [17].

Safety. Severe anaphylaxis with modern IV iron formulations is rare, occurring in approximately 0.7 per million doses according to a 2015 JAMA analysis [18]. Test doses are no longer required for newer formulations. The most common side effect is transient hypophosphatemia with ferric carboxymaltose, which resolves spontaneously in most patients but should be monitored in those receiving repeated courses.

Cost considerations. IV iron is more expensive per dose than oral iron but may be more cost-effective when factoring in faster response, fewer office visits for non-response workup, and avoided hospitalizations. Insurance coverage varies. Most plans cover IV iron when documented oral failure or a qualifying diagnosis is present.

The Diagnostic Workup Beyond Iron Labs

Finding iron deficiency is step one. Finding the cause is step two. Skipping this step can be dangerous.

For premenopausal women with heavy periods, the iron deficiency itself is the expected finding. Treat the iron deficiency and address the menstrual blood loss (hormonal management, gynecologic referral if warranted). A ferritin recheck at 8 to 12 weeks confirms response.

For men and postmenopausal women, the BSG and AGA recommend upper and lower GI endoscopy if no obvious cause is identified [7][11]. Up to 6% of patients with iron deficiency anemia have concurrent upper and lower GI pathology, so both scopes are necessary even if one is positive.

Celiac screening. Tissue transglutaminase IgA antibody is inexpensive and identifies a treatable cause. Celiac disease is present in 3 to 5% of patients with otherwise unexplained iron deficiency [7].

H. pylori testing. H. pylori infection impairs iron absorption independently of GI bleeding. A meta-analysis of 15 randomized trials (N=1,232) published in World Journal of Gastroenterology found that H. pylori eradication alone improved hemoglobin by a mean of 1.5 g/dL without any change in iron supplementation [19].

Urinalysis. Chronic hematuria from bladder or kidney pathology is an underappreciated source of iron loss.

Hereditary hemorrhagic telangiectasia (HHT). In patients with recurrent epistaxis, GI telangiectasias, and refractory iron deficiency, consider HHT screening.

Do not simply refill iron and move on. The cause determines whether the deficiency will recur.

Monitoring and Long-Term Follow-Up

After initiating treatment, follow a structured monitoring plan.

Week 2 to 4. Check a CBC. Hemoglobin should increase by at least 1 g/dL. A rising reticulocyte count confirms the marrow is responding. If hemoglobin has not improved, reassess the diagnosis, check adherence, and consider IV iron.

Week 8 to 12. Recheck ferritin. The goal is ferritin above 50 ng/mL (some guidelines target above 100 ng/mL for patients with heart failure or chronic kidney disease) [20]. If ferritin remains low despite adequate oral dosing, this suggests ongoing loss or malabsorption.

Month 3 to 6. Continue oral iron until ferritin is consistently above target. Premature discontinuation is the most common reason for recurrence.

Annual rechecks. Patients with a history of iron deficiency, especially those with ongoing risk factors (heavy periods, GI disease, vegetarian diet), should have ferritin monitored annually.

Special populations. In heart failure patients, the AFFIRM-AHF trial (N=1,132) demonstrated that IV ferric carboxymaltose reduced total hospitalizations for heart failure by 26% compared to placebo in iron-deficient patients, even those without anemia [20]. The 2021 ESC Heart Failure guidelines now recommend IV iron for all heart failure patients with ferritin <100 ng/mL or ferritin 100 to 299 ng/mL with transferrin saturation <20%.

A ferritin of 30 ng/mL is not "normal" in a symptomatic patient. Treat to a target, not to a reference range.